On Friday, October 18, 2019, Johnson & Johnson Consumer Inc. announced that it is recalling approximately 33,000 bottles of baby powder in the United States after U.S. health regulators found trace amounts of asbestos in samples taken from a bottle purchased online. Asbestos is a known carcinogen that has been linked to mesothelioma. Johnson &...
Johnson & Johnson Hit Hard With Another Jury Verdict in Talc Case
On July 12, 2018, a St. Louis jury awarded $4.69 billion to 22 women finding that Johnson & Johnson knew or should have known that perineal use of its talcum powder products can cause ovarian cancer in women, but failed to provide adequate instructions and warnings. The verdict included $550 million in compensatory damages and...
Judge Declares Mistrial in Johnson & Johnson Talc Mesothelioma Trial
On Tuesday, California Judge, C. Edward Simpson, granted a mistrial in the first lawsuit to go to trial over claims that Johnson & Johnson’s popular talc-based hygiene products can cause mesothelioma, a deadly cancer generally linked to asbestos exposure. (Prior trials have concerned ovarian cancer.) The Judge declared a mistrial because witness testimony referenced ovarian...
BREAKING NEWS: Johnson & Johnson Hit Yet Again With A $417 Million Verdict in CA Talc Trial
Yesterday, in the first California trial over Johnson & Johnson’s talc powder, a Los Angeles jury awarded $417 million (including $347 million in punitive damages meant to punish the company) to a 62 year old woman, Eva Echeverria who developed ovarian cancer after using its talc-based products for feminine hygiene. (Echeverria v. Johnson & Johnson,...
BREAKING NEWS: Johnson & Johnson Hit Again With A $110 Million Verdict in Another State Court Talc Trial
On Thursday, Johnson & Johnson was ordered by a Missouri jury to pay over $110 million to a Virginia woman, Lois Slemp, who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene. Specially, the lawsuit, (along with numerous others filed across the country), alleges that Johnson & Johnson...
4th Ovarian Cancer Talcum Powder Trial To Start Next Week in Missouri
Despite Johnson & Johnson’s attempt to delay the next talcum powder trial, the trial of Nora Daniels, 56, a resident of Columbia, Tennessee will proceed on February 6, 2017. Ms. Daniels alleges that years of using Johnson & Johnson’s baby powder caused her ovarian cancer. Specially, the lawsuit, along with numerous others filed across the...
Baby Powder Cancer Lawsuits Sent to New Jersey Federal Court
On October 4, 2016, the Judicial Panel on Multidistrict Litigation (JPML) issued an order transferring federal cases alleging that women developed ovarian or uterine cancer following use of Johnson & Johnson’s talcum powder products (namely Johnson’s Baby Powder and Shower to Shower body powder) to U.S. District Judge Freda L. Wolfson in the District of New Jersey for...
MISSOURI JURY AWARDS $55 MILLION IN ANOTHER JOHNSON & JOHNSON TALC-POWDER VERDICT
For the second time in only a few months, a jury in St. Louis awarded $55 million in damages to Gloria Ristesund, a woman who used Johnson & Johnson’s talcum powder for feminine hygiene more than 35 years before being diagnosed with ovarian cancer. On Monday, the jury agreed that Johnson and Johnson knew of...
Another Talcum Powder Trial Underway in Missouri
The trial of a Missouri woman, Gloria Ristesund, who contends that her ovarian cancer was caused by exposure to talcum powder is currently underway in the St. Louis Circuit Court. The parties delivered opening statements on April 12th. This is the second Johnson & Johnson baby powder lawsuit to be heard before this court since...
$72 Million Jury Verdict for Cancer Death from Talcum Powder
Johnson & Johnson must pay $72 million to the family of a woman, Jackie Fox who developed fatal ovarian cancer after using the company’s baby powder and another talc-based product, Shower to Shower. The case is Fox v. Johnson & Johnson, No. 1422-CC09012-01, Division 10, Missouri Circuit Court, 22nd Judicial District (St. Louis). It is...